Abstract:Investigations used to aid diagnosis and prognosticate outcomes in ocular inflammatory disorders are based on techniques that have evolved over the last two centuries have dramatically evolved with the advances in molecular biological and imaging technology. Our improved understanding of basic biological processes of infective drives of innate immunity bridging the engagement of adaptive immunity have formed techniques to tailor and develop assays, and deliver targeted treatment options. Diagnostic techniques … Show more
“…Despite the rarity, uveal EMZL should be included in the differential diagnosis of uveal inflammation or tumors, particularly in patients with persistent signs and symptoms. Non-resolving or recurrent masquerade syndromes not responding to standard treatment should lead to prompt biopsy [ 33 ].…”
BackgroundPrimary extranodal marginal zone lymphoma (EMZL) of the uvea is a rare condition and diagnosis may be challenging. We aim to report the clinical, histopathologic and immunohistochemical findings in a case of primary EMZL with diffuse uveal involvement and focal infiltration of the trabecular meshwork.Case presentationA 38-year-old male presented with 2-year progressive vision loss in the right eye. Fundus examination showed choroidal thickening with diffuse retinal pigment epithelium (RPE) changes and inferior exudative retinal detachment. Ultrasonography revealed low-reflective masses with diffuse thickening of the choroid involving the optic nerve and orbit. Despite treatment with steroids, his symptoms progressed over time. One year later, visual acuity of the right eye markedly decreased to no light perception and enucleation was performed. Histopathological findings revealed infiltrates of malignant cells in the choroid, iris, ciliary body and trabecular meshwork. Immunohistochemistry confirmed the diagnosis of primary uveal EMZL.ConclusionsThis is the first case reporting primary EMZL diffusely involving the uvea with focal infiltration of the trabecular meshwork.
“…Despite the rarity, uveal EMZL should be included in the differential diagnosis of uveal inflammation or tumors, particularly in patients with persistent signs and symptoms. Non-resolving or recurrent masquerade syndromes not responding to standard treatment should lead to prompt biopsy [ 33 ].…”
BackgroundPrimary extranodal marginal zone lymphoma (EMZL) of the uvea is a rare condition and diagnosis may be challenging. We aim to report the clinical, histopathologic and immunohistochemical findings in a case of primary EMZL with diffuse uveal involvement and focal infiltration of the trabecular meshwork.Case presentationA 38-year-old male presented with 2-year progressive vision loss in the right eye. Fundus examination showed choroidal thickening with diffuse retinal pigment epithelium (RPE) changes and inferior exudative retinal detachment. Ultrasonography revealed low-reflective masses with diffuse thickening of the choroid involving the optic nerve and orbit. Despite treatment with steroids, his symptoms progressed over time. One year later, visual acuity of the right eye markedly decreased to no light perception and enucleation was performed. Histopathological findings revealed infiltrates of malignant cells in the choroid, iris, ciliary body and trabecular meshwork. Immunohistochemistry confirmed the diagnosis of primary uveal EMZL.ConclusionsThis is the first case reporting primary EMZL diffusely involving the uvea with focal infiltration of the trabecular meshwork.
“…A recent study has observed that mantoux test can be used for the diagnosis of ocular TB, which remains to be least invasive and cost effective procedure. The drawback being that the tuberculin skin test cannot differentiate between infections of Mycobacterium TB from that of atypical Mycobacteria [17]. An epidemiological report published recently from Korea has indicated that with a reaction of >10 mm diameter taken as a cut off, there has been a decrease in the positivity against tuberculin skin test from 2005 (28%) to 2009 (15%), which was associated to BCG vaccination [18].…”
This review reinvents the role of mantoux test/tuberculin skin test (TST) in the laboratory diagnosis of tuberculosis (TB). TB has been the most significant infectious disease responsible for severe morbidity and mortality worldwide. Asia and African continents constitute most of the burden of world TB. Although a treatable infectious disease, the exposed individuals do not always show clinical signs of infection. TB may be present latent in many infected population. Clinical, radiological, cultural and staining methods, molecular techniques and many other advanced laboratory methods are available for the diagnosis of TB. Among the various laboratory techniques available for the diagnosis of TB, Mantoux TST is a low cost and easily done test that if performed and interpreted appropriately can be used for diagnosis of TB.
“…Advanced imaging tools (such as MRI or ultra sono graphy) enable direct visualization and accurate measure ment of joint specific inflammation, at the same time, 9 tools that determine the severity of ocular disease (such as levels of cytokines in tears, impres sion cyto logy, automated grading of conjunctival hyperae mia and in vivo imag ing of immune cells and lymphatics) have advanced the study of ocular surface immun ology. 10 Knowledge of shared and organspecific processes should shape em erging and future therapeutic approaches to dry eye.…”
Rheumatoid arthritis (RA), the most common autoimmune disorder associated with dry eye syndrome, is also associated with sight-threatening ocular diseases such as peripheral ulcerative keratitis, scleritis and corneal melts. Tissue damage on the ocular surface of patients with RA is autoimmune-mediated. Findings from patients with dry eye have implicated defects in innate immunity (Toll-like receptors, S100A and resident antigen-presenting cells), cytokines, chemokines and T helper (TH)-cell subsets (including TH1 and TH17) in disease pathogenesis. Some of these features are probably important in dry eye related to RA, which can occur at a different time from articular disease and is more clinically severe than idiopathic dry eye. Ocular surface immune factors can be influenced by the systemic immune landscape. Depending on the severity of ocular inflammation in RA, treatment can include ciclosporin, topical corticosteroids, tacrolimus, autologous serum and systemic immunosuppression. Tissue damage is treated by inhibiting matrix metalloproteinases. Potential therapeutic strategies benefit from an improved understanding of ocular surface immunology, and include targeting of T-cell subsets, B-cell signalling or cytokines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.